Buckingham Capital Management, Inc. Buys Abbott Laboratories, Taiwan Semiconductor Manufacturing Co, AstraZeneca PLC, Sells Xtrackers MSCI EAFE Hedged Equity, Intel Corp, The Kraft Heinz Co

Dayton, OH, based Investment company Buckingham Capital Management, Inc. buys Abbott Laboratories, Taiwan Semiconductor Manufacturing Co, AstraZeneca PLC, Infosys, KeyCorp, Regeneron Pharmaceuticals Inc, Royal Caribbean Cruises, Alibaba Group Holding, Raymond James Financial Inc, NVIDIA Corp, Novartis AG, Roper Technologies Inc, Eli Lilly and Co, Raytheon Co, L3 Technologies Inc, iShares Core MSCI Emerging Markets, sells Xtrackers MSCI EAFE Hedged Equity, Intel Corp, The Kraft Heinz Co, Biogen Inc, International Paper Co, D.R. Horton Inc, TransCanada Corp, Procter & Gamble Co, Canadian National Railway Co, Invesco, CVS Health Corp, Schwab Short-Term U.S. Treasury, Laboratory Corp of America Holdings, Morgan Stanley, Cerner Corp, McCormick Inc, Schlumberger, Texas Instruments Inc, Air Products & Chemicals Inc, Medtronic PLC, Skechers USA Inc, General Electric Co during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Buckingham Capital Management, Inc.. As of 2019Q1, Buckingham Capital Management, Inc. owns 126 stocks with a total value of $483 million. These are the details of the buys and sells.

For the details of Buckingham Capital Management, Inc.'s stock buys and sells, go to https://www.gurufocus.com/guru/buckingham+capital+management%2C+inc./current-portfolio/portfolio

These are the top 5 holdings of Buckingham Capital Management, Inc.
  1. Vanguard Short-Term Corporate Bond ETF (VCSH) - 537,472 shares, 8.87% of the total portfolio. Shares reduced by 2.57%
  2. Invesco Ultra Short Duration (GSY) - 762,721 shares, 7.94% of the total portfolio. Shares added by 14.02%
  3. Schwab International Equity (SCHF) - 1,154,476 shares, 7.48% of the total portfolio. Shares added by 6.15%
  4. Schwab U.S. Broad Market (SCHB) - 205,346 shares, 2.89% of the total portfolio. Shares added by 1.38%
  5. Apple Inc (AAPL) - 66,746 shares, 2.62% of the total portfolio. Shares added by 1.10%
New Purchase: Infosys Ltd (INFY)

Buckingham Capital Management, Inc. initiated holding in Infosys Ltd. The purchase prices were between $9.47 and $11.06, with an estimated average price of $10.57. The stock is now traded at around $10.35. The impact to a portfolio due to this purchase was 0.2%. The holding were 88,373 shares as of .

New Purchase: Regeneron Pharmaceuticals Inc (REGN)

Buckingham Capital Management, Inc. initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $372.08 and $439.57, with an estimated average price of $411.49. The stock is now traded at around $322.40. The impact to a portfolio due to this purchase was 0.2%. The holding were 2,360 shares as of .

New Purchase: KeyCorp (KEY)

Buckingham Capital Management, Inc. initiated holding in KeyCorp. The purchase prices were between $14.78 and $17.95, with an estimated average price of $16.66. The stock is now traded at around $17.36. The impact to a portfolio due to this purchase was 0.2%. The holding were 60,246 shares as of .

New Purchase: NVIDIA Corp (NVDA)

Buckingham Capital Management, Inc. initiated holding in NVIDIA Corp. The purchase prices were between $127.99 and $183.94, with an estimated average price of $154.95. The stock is now traded at around $173.11. The impact to a portfolio due to this purchase was 0.07%. The holding were 1,920 shares as of .

New Purchase: Roper Technologies Inc (ROP)

Buckingham Capital Management, Inc. initiated holding in Roper Technologies Inc. The purchase prices were between $258.8 and $341.97, with an estimated average price of $302.79. The stock is now traded at around $353.05. The impact to a portfolio due to this purchase was 0.05%. The holding were 689 shares as of .

New Purchase: Novartis AG (NVS)

Buckingham Capital Management, Inc. initiated holding in Novartis AG. The purchase prices were between $73.8 and $84.4, with an estimated average price of $78.6. The stock is now traded at around $81.07. The impact to a portfolio due to this purchase was 0.05%. The holding were 2,364 shares as of .

Added: Abbott Laboratories (ABT)

Buckingham Capital Management, Inc. added to a holding in Abbott Laboratories by 309.62%. The purchase prices were between $66.22 and $80.06, with an estimated average price of $74.34. The stock is now traded at around $76.90. The impact to a portfolio due to this purchase was 0.45%. The holding were 36,321 shares as of .

Added: Taiwan Semiconductor Manufacturing Co Ltd (TSM)

Buckingham Capital Management, Inc. added to a holding in Taiwan Semiconductor Manufacturing Co Ltd by 48.80%. The purchase prices were between $34.36 and $41.04, with an estimated average price of $38.11. The stock is now traded at around $43.79. The impact to a portfolio due to this purchase was 0.38%. The holding were 135,825 shares as of .

Added: AstraZeneca PLC (AZN)

Buckingham Capital Management, Inc. added to a holding in AstraZeneca PLC by 113.18%. The purchase prices were between $35.49 and $43.02, with an estimated average price of $39.37. The stock is now traded at around $37.98. The impact to a portfolio due to this purchase was 0.26%. The holding were 58,095 shares as of .

Added: Royal Caribbean Cruises Ltd (RCL)

Buckingham Capital Management, Inc. added to a holding in Royal Caribbean Cruises Ltd by 31.26%. The purchase prices were between $92.55 and $120.98, with an estimated average price of $113.45. The stock is now traded at around $127.26. The impact to a portfolio due to this purchase was 0.18%. The holding were 31,629 shares as of .

Added: Alibaba Group Holding Ltd (BABA)

Buckingham Capital Management, Inc. added to a holding in Alibaba Group Holding Ltd by 56.23%. The purchase prices were between $130.6 and $187.25, with an estimated average price of $167.49. The stock is now traded at around $181.43. The impact to a portfolio due to this purchase was 0.11%. The holding were 8,316 shares as of .

Added: Raymond James Financial Inc (RJF)

Buckingham Capital Management, Inc. added to a holding in Raymond James Financial Inc by 42.71%. The purchase prices were between $71.54 and $84.46, with an estimated average price of $80.28. The stock is now traded at around $88.05. The impact to a portfolio due to this purchase was 0.1%. The holding were 20,356 shares as of .

Sold Out: The Kraft Heinz Co (KHC)

Buckingham Capital Management, Inc. sold out a holding in The Kraft Heinz Co. The sale prices were between $31.87 and $48.26, with an estimated average price of $41.

Sold Out: Biogen Inc (BIIB)

Buckingham Capital Management, Inc. sold out a holding in Biogen Inc. The sale prices were between $216.71 and $338.96, with an estimated average price of $315.3.

Sold Out: International Paper Co (IP)

Buckingham Capital Management, Inc. sold out a holding in International Paper Co. The sale prices were between $40.36 and $47.74, with an estimated average price of $45.71.

Sold Out: D.R. Horton Inc (DHI)

Buckingham Capital Management, Inc. sold out a holding in D.R. Horton Inc. The sale prices were between $34.66 and $42.54, with an estimated average price of $39.07.

Sold Out: Invesco Ltd (IVZ)

Buckingham Capital Management, Inc. sold out a holding in Invesco Ltd. The sale prices were between $16.43 and $20.24, with an estimated average price of $18.67.

Sold Out: Canadian National Railway Co (CNI)

Buckingham Capital Management, Inc. sold out a holding in Canadian National Railway Co. The sale prices were between $73.17 and $89.48, with an estimated average price of $83.75.



Here is the complete portfolio of Buckingham Capital Management, Inc.. Also check out:

1. Buckingham Capital Management, Inc.'s Undervalued Stocks
2. Buckingham Capital Management, Inc.'s Top Growth Companies, and
3. Buckingham Capital Management, Inc.'s High Yield stocks
4. Stocks that Buckingham Capital Management, Inc. keeps buying